The Pediatrics Department is offering a grant for multidisciplinary research in developmental pharmacodynamics, focusing on pediatric age groups. This grant aims to establish valuable data and understand the pharmacokinetic-pharmacodynamic relationship of drugs used in pediatrics. Applications for this grant should involve basic translational and clinical research efforts. Deadline for submissions is May 07, 2021.
Opportunity ID: 301136
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-18-687 |
Funding Opportunity Title: | Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 01, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2021 |
Current Closing Date for Applications: | May 07, 2021 |
Archive Date: | Jun 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $50,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Special district governments Public housing authorities/Indian housing authorities State governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic translational and clinical research in developmental pharmacodynamics This FOA encourages grant applications that propose studies to increase and establish data on developmental pharmacodynamic in the pediatric age groups and allows the determination of pharmacokinetic-pharmacodynamic relationship of drugs used in this population. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-687.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238739 | May 16, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259718 | May 16, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
301136 RR_SF424_2_0-2.0.pdf
301136 PHS398_CoverPageSupplement_4_0-4.0.pdf
301136 RR_OtherProjectInfo_1_4-1.4.pdf
301136 PerformanceSite_2_0-2.0.pdf
301136 RR_KeyPersonExpanded_2_0-2.0.pdf
301136 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
301136 RR_Budget_1_4-1.4.pdf
301136 RR_SubawardBudget30_1_4-1.4.pdf
301136 PHS398_ModularBudget_1_2-1.2.pdf
301136 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
301136 RR_SF424_2_0-2.0.pdf
301136 PHS398_CoverPageSupplement_5_0-5.0.pdf
301136 RR_OtherProjectInfo_1_4-1.4.pdf
301136 PerformanceSite_2_0-2.0.pdf
301136 RR_KeyPersonExpanded_2_0-2.0.pdf
301136 PHS398_ResearchPlan_4_0-4.0.pdf
301136 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
301136 RR_Budget_1_4-1.4.pdf
301136 RR_SubawardBudget30_1_4-1.4.pdf
301136 PHS398_ModularBudget_1_2-1.2.pdf
301136 PHS_AssignmentRequestForm_3_0-3.0.pdf